semaglutide for heart failure in Patients with Obesity-Related and Type 2 Diabetes More cardiovascular outcomes data in

Once authorization is secured, we provide 24/7 care coordination and support

A 2025 systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders found that tirzepatide (the active ingredient in Mounjaro and Zepbound) reduced hsCRP by approximately 33% and IL-6 by approximately 18% compared to placebo across patients with and without diabetes. A growing body of research suggests this effect occurs through direct action on the NF-B pathway, a master switch of inflammation

This may be a good alternative for people who want a medication that works like Wegovy but dont want to take an injection

Deletion of the laminin alpha4 chain leads to impaired microvessel maturation

GH peptides could theoretically affect blood sugar in diabetic patients